认知障碍中的表观遗传调节:专注于N6-甲基氨酸修饰及其在外科手术期间神经认知障碍中的潜在作用
Ting Liu1, Xiao-Juan Yang1, Lin Zhou2
1School of Anesthesiology Guizhou Medical University Guiyang China.
Ibrain
|September 29, 2025
概括
N6-甲基氨酸 (m6A) 调节了对认知至关重要的基因表达. 本综述探讨了m6A在认知功能中的作用及其与外科手术前神经认知障碍 (PND) 的潜在联系,并提出了未来的治疗点.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) 是哺乳动物中最常见的内部mRNA修饰.
- m6A动态调节基因表达,影响认知功能.
- 外科手术期间的神经认知障碍 (PND) 包括妄,手术后延迟恢复和认知功能障碍.
研究的目的:
- 审查m6A在认知过程中的作用.
- 检查m6A在PND病变发生过程中的潜在参与.
- 确定m6A作为潜在的生物标志物或PND治疗点.
主要方法:
- 这篇叙事综述综合了关于m6A修饰和认知功能的现有文献.
- 来自动物模型的临床前证据分析了m6A与神经炎症,神经退行和神经元损伤有关的证据.
- 考虑了麻醉剂和手术压力对m6A水平的影响.
主要成果:
- m6A调节机制影响神经元发育,突触可塑性和认知.
- m6A失调与神经炎症和神经退行有关,这些机制与PND相关.
- 麻醉剂和手术压力改变海马体m6A水平,m6A蛋白操纵可以改善认知缺陷.
结论:
- m6A 修饰在认知功能中起着重要作用.
- 初步证据表明m6A可能参与PND的发病,尽管直接联系需要进一步调查.
- m6A代表了未来研究PND生物标志物和治疗方法的一个有希望的领域.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Biosynthesis of Nucleic Acids
985
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
985
RNA Editing
9.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K


